The Mechanisms of Acquired Resistance to Anti-Egfr Drugs in Non-Small Cell Lung Cancer Not Associated With T790m Mutation and Their Significance in Clinical Practice

Advances in molecular oncology

doi 10.17650/2313-805x-2018-5-3-17-24